Successful Stenting Followed by Surgery for Perforated Esophageal Cancer Due to Chemotherapy

Teruyuki Kobayashi, Tomoki Makino, Makoto Yamasaki, Koji Tanaka, Masaki Mori, Yuichiro Doki

Research output: Contribution to journalArticle


Perforation of esophageal cancer solely due to preoperative chemotherapy is extremely rare, but can be associated with pyothorax and can be difficult to treat. Here, we report the case of a successfully treated patient with thoracic esophageal cancer who had esophageal perforation during docetaxel, cisplatin, and 5-fluorouracil chemotherapy. A 73-year-old patient had esophageal perforation on the fourth day of the first docetaxel, cisplatin, 5-fluorouracil cycle. The second docetaxel, cisplatin, 5-fluorouracil cycle was administered after insertion of esophageal stenting and subtotal esophagectomy. Early drainage and stent placement were crucial for achieving infection control and allowing for a subsequent complete resection.

Original languageEnglish
Pages (from-to)e361-e363
JournalAnnals of Thoracic Surgery
Issue number6
Publication statusPublished - Dec 2019


All Science Journal Classification (ASJC) codes

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this